港股早評:恒指微幅高開0.05%,金價持續新高黃金股大升
鮑威爾“鷹聲”重創市場,隔夜美股三大指數大跌,熱門中概股多數下跌。港股三大指開盤升跌不一,恒指升0.05%,國指跌0.03%,恒生科技指數跌0.12%。盤面上,大型科技股升跌各異波動不大,騰訊、網易飄紅,美團跌超1%,百度、京東、阿里巴巴小幅下跌;黃金持續刷新歷史高位,黃金股繼續大升,赤峯黃金大升近9%,山東黃金升5%,招金礦業升近4%再創新高,帶領銅、鋁等有色金屬股齊升;石油股、電力股、汽車股、海運股多數上升。另一方面,Deepseek概念股走低,金山雲大跌超7%,蘋果概念股繼續下跌,丘鈦科技、瑞聲科技跌超1%,海運股、汽車股部分下跌。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.